|
|
|
|
|
Product Name
|
Kallikrein 15 peptide (Kallikrein loop)
|
|
Product type
|
Proteins and Peptides
|
|
Peptide
|
Synthetic peptide Kallikrein 15.
This peptide was used as an immunogen for ab28570 - Kallikrein 15 antibody - Kallikrein loop.
|
|
Specificity
|
We have a range of domain specific antibodies for this target. For a full list please see all Kallikrein 15 antibodies
|
|
Tested applications
(see key)
|
ELISA, WB
|
|
Application notes
(see key)
|
Recommended dilutions ELISA: Use at an assay dependent dilution. WB: Use at an assay dependent dilution. This peptide can be used with studies using ab28570. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
|
|
Research areas
|
Cell Biology >> Proteolysis / Ubiquitin >> Proteolytic enzymes >> Serine protease >> Kallikreins Cancer >> Invasion/microenvironment >> ECM >> Extracellular matrix >> Kallikreins Signal Transduction >> Cytoskeleton / ECM >> Extracellular Matrix >> ECM Enzymes >> Kallikreins
|
|
Relevance
|
The human tissue Kallikrein gene family encodes 15 serine proteases. All Kallikreins share structural similarities including cysteine residues, a catalytic triad of His, Asp, and Ser residues, typically five coding exons, and varied intron phases. Kallikreins are predominantly secreted as inactive zymogens prior to activation by cleavage of an N terminal peptide, and all function extracellularly. Kallikreins can be activated autocatalytically, via other Kallikreins, or additional proteases. While structurally similar, Kallikrein family members have distinct functions and have key roles in many physiological and pathological processes. Many human tissue Kallikreins also show promise as cancer biomarkers, which may facilitate earlier detection and characterization of many forms of cancer.
Kallikrein 15 is one of the fifteen kallikrein subfamily members whose gene is located in a cluster on chromosome 19. Increased levels are found in prostate cancer, which indicates its possible use as a diagnostic or prognostic marker for prostate cancer. Four splice variants, each encoding a distinct isoform, have been described.
|
|
|
|
|
Purity
|
>95% by SDS-PAGE
|
|
Storage buffer
|
Preservative: None Constituents: 0.001% Tween 20, 30mM HEPES, 2mM EDTA, 150mM Sodium chloride, pH 6.75
|
|
Form
|
Liquid
|
|
Concentration
|
1.000 mg/ml
|
|
Storage instructions
|
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this Kallikrein 15 peptide (Kallikrein loop) is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
| |
|
Search PubMed (MEDLINE) for references to Kallikrein 15
|
| |
Kallikrein 15 peptide (Kallikrein loop) - more information
|
Customer reviews (feedback) regarding Kallikrein 15 peptide (Kallikrein loop) |
Customer FAQs regarding Kallikrein 15 peptide (Kallikrein loop) |
Protocols for Kallikrein 15 peptide (Kallikrein loop) |
Price and availability of products related to Kallikrein 15 peptide (Kallikrein loop) |
| |
Kallikrein 15 peptide (Kallikrein loop) - related products:
|
|
|
| |
Kallikrein 15 peptide (Kallikrein loop) - other tools:
|
Contact Abcam with a Technical Enquiry about Kallikrein 15 peptide (Kallikrein loop) |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"